The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases
- 1 February 2018
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 182, 115-132
- https://doi.org/10.1016/j.pharmthera.2017.08.015
Abstract
No abstract availableFunding Information
- French Ministry of Research
- Institut National de la Santé et de la Recherche Médicale
- Regional Council of Burgundy
- FEDER
- Association de Cardiologie de Bourgogne
This publication has 200 references indexed in Scilit:
- Osteoprotegerin Inhibits Aortic Valve Calcification and Preserves Valve Function in Hypercholesterolemic MicePLOS ONE, 2013
- Participation of blood vessel cells in human adaptive immune responsesTrends in Immunology, 2011
- Sclerostin: Current Knowledge and Future PerspectivesCalcified Tissue International, 2010
- IGF-1, oxidative stress and atheroprotectionTrends in Endocrinology & Metabolism, 2010
- Relation of Multiple Inflammatory Biomarkers to Incident Atrial FibrillationThe American Journal of Cardiology, 2009
- RANK, RANKL and osteoprotegerin in bone biology and diseaseCurrent Reviews in Musculoskeletal Medicine, 2009
- Osteoprotegerin, vascular calcification and atherosclerosisAtherosclerosis, 2008
- Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-α associated with induction of angiopoietin-2☆Cardiovascular Research, 2007
- The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal womenOsteoporosis International, 2005
- The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal womenOsteoporosis International, 2005